1. Home
  2. MAIA vs RVSB Comparison

MAIA vs RVSB Comparison

Compare MAIA & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • RVSB
  • Stock Information
  • Founded
  • MAIA 2018
  • RVSB 1923
  • Country
  • MAIA United States
  • RVSB United States
  • Employees
  • MAIA N/A
  • RVSB N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • RVSB Savings Institutions
  • Sector
  • MAIA Health Care
  • RVSB Finance
  • Exchange
  • MAIA Nasdaq
  • RVSB Nasdaq
  • Market Cap
  • MAIA 46.7M
  • RVSB 115.6M
  • IPO Year
  • MAIA 2022
  • RVSB 1993
  • Fundamental
  • Price
  • MAIA $1.88
  • RVSB $5.69
  • Analyst Decision
  • MAIA
  • RVSB Buy
  • Analyst Count
  • MAIA 0
  • RVSB 1
  • Target Price
  • MAIA N/A
  • RVSB $7.00
  • AVG Volume (30 Days)
  • MAIA 529.1K
  • RVSB 253.4K
  • Earning Date
  • MAIA 08-08-2025
  • RVSB 07-24-2025
  • Dividend Yield
  • MAIA N/A
  • RVSB 1.40%
  • EPS Growth
  • MAIA N/A
  • RVSB 27.97
  • EPS
  • MAIA N/A
  • RVSB 0.23
  • Revenue
  • MAIA N/A
  • RVSB $50,239,000.00
  • Revenue This Year
  • MAIA N/A
  • RVSB $12.68
  • Revenue Next Year
  • MAIA N/A
  • RVSB $11.53
  • P/E Ratio
  • MAIA N/A
  • RVSB $24.78
  • Revenue Growth
  • MAIA N/A
  • RVSB 3.95
  • 52 Week Low
  • MAIA $1.40
  • RVSB $3.68
  • 52 Week High
  • MAIA $4.24
  • RVSB $6.59
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 56.41
  • RVSB 57.09
  • Support Level
  • MAIA $1.80
  • RVSB $5.65
  • Resistance Level
  • MAIA $2.15
  • RVSB $5.85
  • Average True Range (ATR)
  • MAIA 0.13
  • RVSB 0.14
  • MACD
  • MAIA 0.02
  • RVSB 0.04
  • Stochastic Oscillator
  • MAIA 60.00
  • RVSB 71.15

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: